| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/10/2003 | US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030130168 Reverse-turn mimetics and methods relating thereto |
| 07/10/2003 | US20030130165 Method for treating neurodegenerative disorders |
| 07/10/2003 | US20030129750 Inducing vascular growth in tissue via administration of cytokine, chemokine, or chemoattractant; for treatment of cardiac ischemia; tissue engineering |
| 07/10/2003 | US20030129728 Disrupting genes and mixing with plasmids/DNA vaccine; immunology; gene therapy; aging resistance |
| 07/10/2003 | US20030129698 Involved in homo and heterotrimerization or oligomerization |
| 07/10/2003 | US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis |
| 07/10/2003 | US20030129663 Methods and compositions for modulating oxidized ldl transport |
| 07/10/2003 | US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity |
| 07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/10/2003 | US20030129294 Hydroquinone-substituted fatty acid for use in foods; lipase inhibitors; peroxisome proliferator activated receptors; antiaging agents |
| 07/10/2003 | US20030129241 Effective amount of a vasoactive prostaglandin, a polysaccharide thickener, a lipophilic component, and an acidic buffer system |
| 07/10/2003 | US20030129188 Peptide mimetics; catalytic antibodies such as aldolase, beta-lactamase, esterase, or amidase; for treatment of angiogenesis, bone metabolism disorders, inflammation, or cell growth disorders |
| 07/10/2003 | US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 07/10/2003 | US20030129186 Compositions and methods for modulating blood-brain barrier transport |
| 07/10/2003 | US20030129176 Atherosclerosis-associated genes |
| 07/10/2003 | US20030129134 Method of monitoring neuroprotective treatment |
| 07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
| 07/10/2003 | CA2482392A1 Carboxylic acid derivative |
| 07/10/2003 | CA2471635A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 07/10/2003 | CA2471348A1 Quinazolinone derivative |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471297A1 Human netrin receptor and uses thereof |
| 07/10/2003 | CA2471236A1 Urea derivatives |
| 07/10/2003 | CA2471217A1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
| 07/10/2003 | CA2470781A1 Cystine-knot fold protein |
| 07/10/2003 | CA2470696A1 Pecam-1 modulation |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
| 07/10/2003 | CA2469690A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | CA2468619A1 Adiponectin fragments and conjugates |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/09/2003 | EP1325921A2 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators |
| 07/09/2003 | EP1325920A1 N-substituted benzothiophenesulfonamide derivatives |
| 07/09/2003 | EP1325918A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 07/09/2003 | EP1325916A1 Piperazinyl-substituted phenyl pyrimidine derivatives useful in the treatment or prevention of disorders of the central nervous system |
| 07/09/2003 | EP1325904A1 Novel aliphatic compounds, process for their preparation and their usage |
| 07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 07/09/2003 | EP1325757A1 Embolic materials |
| 07/09/2003 | EP1325745A1 Preventives and remedies for complications of diabetes |
| 07/09/2003 | EP1325341A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 07/09/2003 | EP1325122A2 Modulation of the transcription of pro-inflammatory gene products |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325116A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 07/09/2003 | EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 07/09/2003 | EP1325019A1 Antisense modulation of clusterin expression |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1325008A1 Piperazine derivatives |
| 07/09/2003 | EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 07/09/2003 | EP1325001A1 Anticholinergic agents that can be used as medicaments and method for the production thereof |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
| 07/09/2003 | EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
| 07/09/2003 | EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 07/09/2003 | EP1324972A1 Dihydroxy open-acid salt of simvastatin |
| 07/09/2003 | EP1324780A2 Cardiac arrhythmia treatment methods |
| 07/09/2003 | EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions |
| 07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
| 07/09/2003 | EP1324771A2 Therapeutic antibodies |
| 07/09/2003 | EP1324766A2 Methods and compositions for the treatment of peripheral artery disease |
| 07/09/2003 | EP1324760A1 Creatine ester pronutrient compounds and formulations |
| 07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
| 07/09/2003 | EP1324755A1 Pharmaceutical solutions of modafinil compounds |
| 07/09/2003 | EP1324750A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 07/09/2003 | EP1235810B1 Process of making substituted pyrazoles |
| 07/09/2003 | EP1175210A4 Increasing cerebral bioavailability of drugs |
| 07/09/2003 | EP1156798B1 Felbamate derived compounds |
| 07/09/2003 | EP1040096B1 Neuroprotective agents |
| 07/09/2003 | EP0966465B1 Inhibitors of impdh enzyme |
| 07/09/2003 | EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 07/09/2003 | CN1429267A Neural progenitor cell populations |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429215A 三唑衍生物 Triazole derivatives |
| 07/09/2003 | CN1429212A Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 07/09/2003 | CN1428336A Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 07/09/2003 | CN1428173A Recombinant hirudin oral enteric soluble slowly-releasing preparation |
| 07/09/2003 | CN1428171A Chinese medicine for curing primary hypertension and its preparation method |
| 07/09/2003 | CN1428170A Effective component of safflower, its powder injection, preparation method and medicinal application |
| 07/09/2003 | CN1428164A Thrombosis-eliminating collaterals-activating capsule |
| 07/09/2003 | CN1113895C Growth hormone secretagogues |
| 07/09/2003 | CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives |
| 07/09/2003 | CN1113872C Tricyclicbenzo [e] isoindole and benzo [h] isoquinoline |
| 07/09/2003 | CN1113669C Method for treating endothelial injury |
| 07/09/2003 | CN1113654C Compounds and pharmaceutical compositions containing them |
| 07/09/2003 | CN1113652C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignant tumour |
| 07/08/2003 | US6590079 Vitazin antibody; treating angiogenesis or restenosis |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/08/2003 | US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |